Evidence map›Paper›PMID 40659629›Full record

ArticleNature communications2025

Quantitative phase imaging with temporal kinetics predicts hematopoietic stem cell diversity.

Takao Yogo, Yuichiro Iwamoto, Hans Jiro Becker, Takaharu Kimura, Reiko Ishida, Ayano Sugiyama-Finnis, Tomomasa Yokomizo, Toshio Suda, Sadao Ota, Satoshi Yamazaki

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Takao YogoDivision of Cell Regulation, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. takayogo0430@g.ecc.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0003-4738-5668
Yuichiro IwamotoResearch Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0009-0008-0857-665X
Hans Jiro BeckerDivision of Cell Regulation, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0003-3058-9859
Takaharu KimuraDivision of Cell Regulation, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-1642-2908
Reiko IshidaDivision of Cell Regulation, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Ayano Sugiyama-FinnisDivision of Cell Regulation, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Tomomasa YokomizoDepartment of Microscopic and Developmental Anatomy, Tokyo Women's Medical University, Tokyo, Japan.
Toshio SudaInternational Research Center for Medical Sciences, Kumamoto University, Tokyo, Japan.ORCID http://orcid.org/0000-0001-7540-1771
Sadao OtaResearch Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
Satoshi YamazakiDivision of Cell Regulation, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. y-sato4@ims.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0003-4249-3854

Funding

MEXT | Japan Society for the Promotion of Science (JSPS) #20K21612MEXT | Japan Society for the Promotion of Science (JSPS) #24K02478MEXT | Japan Society for the Promotion of Science (JSPS) #24K19192
6 · The paper itself

Abstract

Innovative identification technologies for hematopoietic stem cells (HSCs) have expanded the scope of stem cell biology. Clinically, the functional quality of HSCs critically influences the safety and therapeutic efficacy of stem cell therapies. However, most analytical techniques capture only a single snapshot, disregarding the temporal context. A comprehensive understanding of the temporal heterogeneity of HSCs necessitates live-cell, real-time and non-invasive analysis. Here, we developed a prediction system for HSC diversity by integrating single-HSC ex vivo expansion technology with quantitative phase imaging (QPI)-driven machine learning. By analyzing the cellular kinetics of individual HSCs, we discovered previously undetectable diversity that snapshot analysis cannot resolve. The QPI-driven algorithm quantitatively evaluates stemness at the single-cell level and leverages temporal information to significantly improve prediction accuracy. This platform advances the field from snapshot-based identification of HSCs to dynamic, time-resolved prediction of their functional quality based on past cellular kinetics.

Indexed as

Hematopoietic Stem CellsAlgorithmsAnimalsHumansKineticsMachine LearningMiceMice, Inbred C57BLQuantitative Phase ImagingSingle-Cell Analysis

Identifiers

PMID40659629
PMCPMC12260078

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.